

PARTNERSHIPS
Deploying world-leading capabilities through strategic partnerships
IMIDomics is supported by an extensive network of industry-leading partners at each stage of our Clinical Discovery Engine
Academic
Vall d’Hebron Institute of Research
VHIR is a public sector institution that promotes and develops biomedical research, innovation, and teaching at Vall d'Hebron University Hospital. Since 1994, VHIR has been working to identify and implement new solutions to society's health problems, achieving leadership and excellence in clinical and translational biomedical research in the national and international spheres.
Discovery and Development
Evotec
Evotec has established itself as a global platform company, leveraging its data-driven multimodality platform for both proprietary as well as partnered research, and applying a unique combination of innovative technologies for the discovery and development of first-in-class and best-in-class pharmaceutical products. Evotec operates globally with more than 4,500 highly qualified people at 17 sites in six countries across Europe and the USA.
GET IN TOUCH
Help us shape the future of immune-mediated inflammatory disease (IMID) medicines

Our work is made possible through our partnerships with industry-leading experts and organizations. We’re always looking for opportunities to expand our network and accelerate the development of medicines for IMID patients. If you are interested in working with us, we’d love to hear from you.
Discovering and developing the next generation of medicines for immune-mediated inflammatory diseases